FDA 510(k) Clearance Establishes Broad Intended Use for Copan's PhenoMATRIX®, Expanding Clinical Microbiology Capabilities

Contributed by: PR Newswire

Images

PR Newswire associated0
PR Newswire associated1
PR Newswire associated2

Tags

Copan-PhenoMATRIX®

More Like This

Sectra and Leica Biosystems first in the world to gain FDA clearance to utilize DICOM images for pathology diagnostics

Scopio Labs Achieves EU IVDR Certification for AI-Powered Full-Field Digital Morphology Platforms

PR Newswire associated0

Leica Biosystems Expands Clinical Digital Pathology Portfolio with Multiple Launches at DPAI 2025

ACCESS Newswire associated1

Biolog Enters the European Diagnostic Market, Bringing 45 Years of Anaerobic Culture Excellence

PR Newswire associated0

Leica Biosystems Unveils Next-Gen Pathology Portfolio at ECDP 2025

Business Wire logo

Thermo Fisher Scientific Updates Chromosomal Microarray Analysis Solutions to Comply with IVDR Regulation

PR Newswire associated0

Hamamatsu Photonics introduces CYTOQUBE, a new cell analyzer combining light-sheet optics and image analysis in a fast, user-friendly system for 3D cell screening assays

GlobeNewswire associated0

BioAro launches AI-Driven PanOmiQ with Ultrafast Whole Genome Sequencing Analysis Technology